A recent study has found that women with hypertension who take beta-blockers may face a higher risk of heart failure than men ...

Hopefully, the approval will help prevent shortages triggered by demand for injectable weight loss drugs such as semaglutide ...

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...

Phenylephrine is used in popular versions of Sudafed, Dayquil, and other medications, but experts have long questioned its effectiveness.

The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep expert Dr. Wendy Troxel discusses the impact of the new development.

The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

At a Royal Society of Medicine conference on cosmetic surgery last month, I listened to an expert in psychology list the ...

It's the third hypertension drug we've seen recalled in a month, with scientists flagging "global safety concerns" with this ...

The United Kingdom Department of Health and Social Care has placed a permanent, indefinite ban on puberty blockers, extending ...